Skip to content
Research Article Open access CC BY 4.0

Analysis and Evaluation of the Effects of Melatonin on Oral Keratinocytes: A Pilot Study

Megan Tufteland, Allison Jae Lenon, Spencer Carlile, Karl Kingsley

Journal of Complementary and Alternative Medical Research · pp. 36–49 · Published 17 May 2022

10.9734/jocamr/2022/v18i130344

Abstract

Objective: Twenty to 30 percent of children in cross-sectional studies have significant bedtime problems or night waking. Melatonin, a synthetic form of the hormone produced by the pineal gland as a biomarker of the circadian system, is a commonly used nonprescription pharmacologic treatment for sleep disorders in children. Many studies have demonstrated the effect of melatonin supplementation on sleep duration and sleep quality, which can improve overall systemic health and disease prevention. However, despite the growing number of studies demonstrating the effects of melatonin to improve disordered sleep, no available studies have evaluated the effects of melatonin on normal oral tissues. Based upon this lack of knowledge, the primary objective of this study is to evaluate any potential effects of melatonin on normal oral cells and tissues within the physiologically relevant (supplementation) range. Methods: Normal oral keratinocytes (OKF4) and human gingival fibroblasts (HGF-1) were obtained and cultured for this study. Melatonin was administered in 96-well growth assays at supplement-equivalent physiologic concentrations at the low, mid and high range (1, 5 and 10 ug/uL) to determine any effects on cellular growth and proliferation. Changes in cellular viability and expression of cell cycle and apoptosis-related pathways were also evaluated. Results: Curvilinear U-shaped dose responses were observed in OKF cells under melatonin administration, ranging from -11.4% (low), to a maximum of -13.6% (mid) and  -5.0% (high) compared with non-treated controls, p=0.029. Dose-responses among HGF-1 cells ranged from +12.1% (low), +17.4% (mid), and +5.0% (high), p=0.021. No changes in cellular viability were observed between control and experimental cells. However, qPCR screening of total RNA revealed significant changes in cell cycle related pathways, including c-myc, GAPDH and P53 but no changes in any apoptosis-related pathways, including Bcl-2, Bax, caspase-3, caspase-8 and caspase-9. Conclusions: This study demonstrated that melatonin does affect growth but not viability among these cell lines, which was found to be dose-dependent. These results suggest that melatonin may have some limited effects on oral tissues that may influence wound healing and repair but may not affect normal physiologic function or other cellular pathways. In agreement with other pediatric literature supporting the safety of melatonin use, this pilot study does not reveal any deleterious effects that would caution against its use in children or adults.

Melatonin oral keratinocyte gingival fibroblast growth

References (57)

  1. 1 Melatonin: Both master clock output and internal time-giver in the circadian clocks network [DOI]
  2. 2 Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease [DOI]
  3. 3 A Clinical Guide to Pediatric Sleep: Diagnosis and Management of Sleep Problems [DOI]
  4. 4 A practical approach to circadian rhythm sleep disorders [DOI]
  5. 5 Is Melatonin the Cornucopia of the 21st Century? [DOI]
  6. 6 Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials [DOI]
  7. 7 Constitutive and UV‐induced metabolism of melatonin in keratinocytes and cell‐free systems [DOI]
  8. 8 Keeping circadian time with hormones [DOI]
  9. 9 Melatonin mediates mucosal immune cells, microbial metabolism, and rhythm crosstalk: A therapeutic target to reduce intestinal inflammation [DOI]
  10. 10 Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma [DOI]
  11. 11 The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators [DOI]
  12. 12 Eat, sleep, repeat – endocrine regulation of behavioural circadian rhythms [DOI]
  13. 13 Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis [DOI]
  14. 14 Melatonin as a Topical/Systemic Formulation for the Management of Periodontitis: A Systematic Review [DOI]
  15. 15 The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders [DOI]
  16. 16 The physiological role of hormones in saliva [DOI]
  17. 17 Pharmacologic Treatment of Pediatric Insomnia [DOI]
  18. 18 Pediatric Sleep Pharmacology [DOI]
  19. 19 Review: Identification and Management of Circadian Rhythm Sleep Disorders as a Transdiagnostic Feature in Child and Adolescent Psychiatry [DOI]
  20. 20 Dental methacrylates may exert genotoxic effects via the oxidative induction of DNA double strand breaks and the inhibition of their repair [DOI]
  21. 21 Anti-fibrotic and anti-inflammatory properties of melatonin on human gingival fibroblasts in vitro [DOI]
  22. 22 The Anti-Wrinkle Mechanism of Melatonin in UVB Treated HaCaT Keratinocytes and Hairless Mice via Inhibition of ROS and Sonic Hedgehog Mediated Inflammatory Proteins [DOI]
  23. 23 Prescription Drugs Used in Insomnia [DOI]
  24. 24 Differential MicroRNA Expression of miR-21 and miR-155 within Oral Cancer Extracellular Vesicles in Response to Melatonin [DOI]
  25. 25 Sleep bruxism and oral health‐related quality of life in children: A systematic review [DOI]
  26. 26 Efficacy and safety of supplemental melatonin for delayed sleep–wake phase disorder in children: an overview [DOI]
  27. 27 Melatonin and Cardioprotection in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [DOI]
  28. 28 Insomnia: the Sleeping Giant of Pediatric Public Health [DOI]
  29. 29 4PBA strongly attenuates endoplasmic reticulum stress, fibrosis, and mitochondrial apoptosis markers in cyclosporine treated human gingival fibroblasts [DOI]
  30. 30 Systematic review and meta-analysis on the adjunctive use of host immune modulators in non-surgical periodontal treatment in healthy and systemically compromised patients [DOI]
  31. 31 Melatonin receptors, brain functions, and therapies [DOI]
  32. 32 Effects of melatonin on the proliferation and differentiation of human dental pulp cells [DOI]
  33. 33 The efficacy of combined bright light and melatonin therapies on sleep and circadian outcomes: A systematic review [DOI]
  34. 34 Medications Used for Pediatric Insomnia [DOI]
  35. 35 Regulatory aspects and evidences of melatonin use for sleep disorders and insomnia: an integrative review [DOI]
  36. 36 Effects of exogenous melatonin on sleep quality and menopausal symptoms in menopausal women: a systematic review and meta-analysis of randomized controlled trials [DOI]
  37. 37 Predictors of diagnostically defined insomnia in child and adolescent community samples: a literature review [DOI]
  38. 38 Melatonin secretion and metabolism in patients with hepatic encephalopathy [DOI]
  39. 39 Stimulation of MMP-9 of oral epithelial cells by areca nut extract is related to TGF-β/Smad2-dependent and –independent pathways and prevented by betel leaf extract, hydroxychavicol and melatonin [DOI]
  40. 40 Modification of gene expression by melatonin in UVB-irradiated HaCaT keratinocyte cell lines using a cDNA microarray [DOI]
  41. 41 Pediatric insomnia: new insights in clinical assessment and treatment option [DOI]
  42. 42 Just Let Me Sleep in [DOI]
  43. 43 Serotonin and melatonin secretion and metabolism in patients with liver cirrhosis [DOI]
  44. 44 The anti-oxidant effects of melatonin derivatives on human gingival fibroblasts [DOI]
  45. 45 Differential exosome miRNA expression in oral cancer stem cells [DOI]
  46. 46 Characterization of Dental Pulp Stem Cell Responses to Functional Biomaterials Including Mineralized Trioxide Aggregates [DOI]
  47. 47 Myths and Evidence Regarding Melatonin Supplementation for Occasional Sleeplessness in the Pediatric Population [DOI]
  48. 48 Headache and Sleep Disturbances in the Pediatric Population [DOI]
  49. 49 A role for the clock period circadian regulator 2 gene in regulating the clock gene network in human oral squamous cell carcinoma cells [DOI]
  50. 50 Alterations in Oral Cancer Gene Expression in Response to Melatonin [DOI]
  51. 51 Circadian Rhythm Dysregulation and Restoration: The Role of Melatonin [DOI]
  52. 52 Safety of higher doses of melatonin in adults: A systematic review and meta‐analysis [DOI]
  53. 53 Prevalence of Sleep Disturbances in Pediatric Cancer Patients and Their Diagnosis and Management [DOI]
  54. 54 Therapeutic Effects of Melatonin on Ocular Diseases: Knowledge Map and Perspective [DOI]
  55. 55 Effects of melatonin on the Bisphenol-A- induced cytotoxicity and genetic toxicity in colon cancer cell lines, normal gingival cell lines, and bone marrow stem cell lines [DOI]
  56. 56 Topical Melatonin Exerts Immunomodulatory Effect and Improves Dermatitis Severity in a Mouse Model of Atopic Dermatitis [DOI]
  57. 57 A Systematic Review on Attachment and Sleep at Preschool Age [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

27

Page views

0

PDF downloads

4

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.